» Articles » PMID: 14771334

The Use of Radioactive Phosphorus in the Treatment of Carcinoma of the Breast with Widespread Metastases to Bone

Overview
Specialty Radiology
Date 1950 Oct 1
PMID 14771334
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases.

Patel C, Wadas T, Shiozawa Y Molecules. 2021; 26(8).

PMID: 33918705 PMC: 8070008. DOI: 10.3390/molecules26082162.


DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis-Challenges and Critical Points in Implementation into Clinical Routine.

Meisenheimer M, Kurpig S, Essler M, Eppard E Molecules. 2020; 25(13).

PMID: 32629930 PMC: 7412164. DOI: 10.3390/molecules25132988.


Treatment of Bone Metastasis with Bone-Targeting Radiopharmaceuticals.

Choi J Nucl Med Mol Imaging. 2018; 52(3):200-207.

PMID: 29942398 PMC: 5995773. DOI: 10.1007/s13139-017-0509-2.


Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons.

Das T, Banerjee S Clin Exp Metastasis. 2016; 34(1):1-10.

PMID: 27988895 DOI: 10.1007/s10585-016-9831-9.


Monomethyl Auristatin E Phosphate Inhibits Human Prostate Cancer Growth.

Cunningham D, Parajuli K, Zhang C, Wang G, Mei J, Zhang Q Prostate. 2016; 76(15):1420-30.

PMID: 27325602 PMC: 5033698. DOI: 10.1002/pros.23226.